BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32274657)

  • 1. StarD13: a potential star target for tumor therapeutics.
    Jaafar L; Chamseddine Z; El-Sibai M
    Hum Cell; 2020 Jul; 33(3):437-443. PubMed ID: 32274657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. StarD13 differentially regulates migration and invasion in prostate cancer cells.
    Jaafar L; Fakhoury I; Saab S; El-Hajjar L; Abou-Kheir W; El-Sibai M
    Hum Cell; 2021 Mar; 34(2):607-623. PubMed ID: 33420961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
    Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
    Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of StarD13 on colorectal cancer proliferation, motility and invasion.
    Nasrallah A; Saykali B; Al Dimassi S; Khoury N; Hanna S; El-Sibai M
    Oncol Rep; 2014 Jan; 31(1):505-15. PubMed ID: 24253896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
    El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
    Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion.
    Hanna S; Khalil B; Nasrallah A; Saykali BA; Sobh R; Nasser S; El-Sibai M
    Int J Oncol; 2014 May; 44(5):1499-511. PubMed ID: 24627003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RhoGAP Stard13 controls insulin secretion through F-actin remodeling.
    Naumann H; Rathjen T; Poy MN; Spagnoli FM
    Mol Metab; 2018 Feb; 8():96-105. PubMed ID: 29310936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. StARD13(Dlc-2) RhoGap mediates ceramide activation of phosphatidylglycerolphosphate synthase and drug response in Chinese hamster ovary cells.
    Hatch GM; Gu Y; Xu FY; Cizeau J; Neumann S; Park JS; Loewen S; Mowat MR
    Mol Biol Cell; 2008 Mar; 19(3):1083-92. PubMed ID: 18162584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42.
    Abdellatef S; Fakhoury I; Haddad MA; Jaafar L; Maalouf H; Hanna S; Khalil B; El Masri Z; Hodgson L; El-Sibai M
    Eur J Cell Biol; 2022 Jan; 101(1):151197. PubMed ID: 34958986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
    Sun J; Barbieri JT
    J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLC-1:a Rho GTPase-activating protein and tumour suppressor.
    Durkin ME; Yuan BZ; Zhou X; Zimonjic DB; Lowy DR; Thorgeirsson SS; Popescu NC
    J Cell Mol Med; 2007; 11(5):1185-207. PubMed ID: 17979893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho regulation: DLC proteins in space and time.
    Braun AC; Olayioye MA
    Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The
    Hu J; Li X; Guo X; Guo Q; Xiang C; Zhang Z; Xing Y; Xi T; Zheng L
    J Cell Sci; 2017 Oct; 130(19):3399-3413. PubMed ID: 28818997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GAP-independent functions of DLC1 in metastasis.
    Barras D; Widmann C
    Cancer Metastasis Rev; 2014 Mar; 33(1):87-100. PubMed ID: 24338004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
    Ching YP; Wong CM; Chan SF; Leung TH; Ng DC; Jin DY; Ng IO
    J Biol Chem; 2003 Mar; 278(12):10824-30. PubMed ID: 12531887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The STAR of the DLC family.
    El-Sitt S; El-Sibai M
    J Recept Signal Transduct Res; 2013; 33(1):10-3. PubMed ID: 23316797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network.
    Zheng L; Zhang Z; Zhang S; Guo Q; Zhang F; Gao L; Ni H; Guo X; Xiang C; Xi T
    Mol Pharm; 2018 Jun; 15(6):2123-2132. PubMed ID: 29733656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
    Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
    Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.
    Khalil BD; Hanna S; Saykali BA; El-Sitt S; Nasrallah A; Marston D; El-Sabban M; Hahn KM; Symons M; El-Sibai M
    Exp Cell Res; 2014 Feb; 321(2):109-22. PubMed ID: 24333506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.